YES! Beat Liver Tumors

Cordially Invites You to

A Briefing

New Cancer Therapies to Beat Liver Tumors

 

More than 200,000 Americans are diagnosed annually with liver cancer or with cancer that has metastasized to the liver.  Until now, most have believed that liver tumors indicate that a patient will soon die.  Fortunately, early detection and cutting-edge new treatments are rapidly changing this short-term diagnosis for thousands of cancer patients.  Unfortunately, many cancer patients, caregivers, and even physicians remain unaware and uneducated about these treatment options.

 

YES! Beat Liver Tumors, a nationwide organization dedicated to the support of patients diagnosed with primary or metastatic liver tumors, invites you to change your perceptions by learning of these new treatments from leading physicians in their field and from caregivers and patients who have experienced their benefits first-hand.

 

Monday, February 7, 2011

12:00 noon to 1:30 pm

Capitol Visitor Center, Room SVC 200-201

A light lunch will be available

 

Ms. Suzanne Lindley, Co-founder, YES! Beat Liver Tumors, stage IV colon cancer survivor, Canton, TX.

Dr. Andrew Kennedy, MD, FACRO, Co-Medical Director, Wake Radiology Oncology, Cary, NC.

Dr. Stephen Cohen, MD, Acting Chief for Gastrointestinal Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA.

Ms. Bonita Jones, RN, MSN, CNS-BC, CRN, Medical Imaging Department, Banner Health, Phoenix, AZ

Dr. Dai “Dave” J. Li, MD,M.Sc., PhD, Chief Medical Director, Wako Diagnostics, Richmond, VA

Dr. Constantinos T. Sofocleous, MD, PhD, FSIR, Associate Professor, Weill Medical College, Cornell University, Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY. 

Mr. Brian MacLeod, stage IV colon cancer survivor, Blaine, WA.

Ms. Miriam Liggett, stage IV breast cancer survivor, Raleigh, NC.

Ms. Erica Paul, stage IV colon cancer survivor, Reston, VA.

 

This briefing is free and open to the public, but space is limited. Please RSVP by calling 1-877-937-7478 or emailing slindley@beatlivertumors.org.  The briefing sponsor is a 501(c)3 organization and does not lobby.